# Bioequivalence Study of Two Dabigatran Etexilate Mesylate Capsules in Healthy Subjects

> **NCT06876623** · PHASE1 · COMPLETED · sponsor: **The Affiliated Hospital Of Guizhou Medical University** · enrollment: 88 (actual)

## Conditions studied

- Bioequivalence of Dabigatran Etexilate Mesylate Capsules From Two Different Manufacturers in Healthy Chinese Subjects

## Interventions

- **DRUG:** dabigatran etexilate mesylate capsules 150mg

## Key facts

- **NCT ID:** NCT06876623
- **Lead sponsor:** The Affiliated Hospital Of Guizhou Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-10
- **Primary completion:** 2020-06-12
- **Final completion:** 2020-06-12
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2025-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06876623

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06876623, "Bioequivalence Study of Two Dabigatran Etexilate Mesylate Capsules in Healthy Subjects". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06876623. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*